HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lingyun Cheng Selected Research

Diabetic Retinopathy (Retinopathy, Diabetic)

1/2023DIRECT MACULAR HOLE MANIPULATION RESULTS IN HIGH SUCCESS RATE IN SECONDARY MACULAR HOLE REPAIR.
11/2022Effective treatment of retinal neovascular leakage with fusogenic porous silicon nanoparticles delivering VEGF-siRNA.
10/2019ANATOMICAL AND FUNCTIONAL TESTING IN DIABETIC PATIENTS WITHOUT RETINOPATHY: Results of Optical Coherence Tomography Angiography and Visual Acuity Under Varying Contrast and Luminance Conditions.
5/2013Influence of scanning density on macular choroidal volume measurement using spectral-domain optical coherence tomography.
5/2013Characterization of microaneurysm closure after focal laser photocoagulation in diabetic macular edema.
10/2011Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lingyun Cheng Research Topics

Disease

24Macular Degeneration (Age-Related Maculopathy)
10/2021 - 10/2002
14Choroidal Neovascularization
05/2020 - 10/2002
12Macular Edema
11/2022 - 09/2003
9Retinitis
01/2015 - 02/2002
6Inflammation (Inflammations)
01/2024 - 03/2006
6Diabetic Retinopathy (Retinopathy, Diabetic)
01/2023 - 10/2011
6Retinal Diseases
12/2021 - 01/2002
6Epiretinal Membrane (Epiretinal Membranes)
04/2012 - 09/2003
5Uveitis
04/2015 - 09/2003
4Myopia
01/2024 - 09/2008
4Infections
01/2023 - 02/2002
4Proliferative Vitreoretinopathy
10/2021 - 01/2012
4Cataract (Cataracts)
11/2020 - 02/2002
4Toxic Optic Neuropathy
07/2014 - 01/2012
4Cytomegalovirus Retinitis
04/2011 - 09/2003
3Retinal Neovascularization
11/2022 - 01/2002
3Retinal Detachment (Retinal Detachments)
12/2020 - 07/2007
3Cicatrix (Scar)
11/2018 - 06/2013
3Hemorrhage
01/2013 - 10/2004
3Burns
07/2007 - 10/2004
2Wounds and Injuries (Trauma)
10/2021 - 01/2010
2Pain (Aches)
06/2021 - 12/2005
2Choroidal Effusions
06/2016 - 04/2015
2Microaneurysm
05/2013 - 05/2012
2Geographic Atrophy
07/2011 - 09/2009
2Melanoma (Melanoma, Malignant)
03/2011 - 09/2002
2Edema (Dropsy)
03/2010 - 10/2007
2Gliosis
08/2009 - 04/2006
2Neoplasms (Cancer)
07/2008 - 09/2002
2Retinal Perforations
10/2004 - 08/2002
1COVID-19
01/2023
1Meibomian Gland Dysfunction
10/2022
1Dry Eye Syndromes (Dry Eye Syndrome)
10/2022
1Weight Loss (Weight Reduction)
01/2022
1Eye Injuries (Eye Injury)
10/2021
1Retinal Vein Occlusion
05/2020
1Retinitis Pigmentosa (Pigmentary Retinopathy)
09/2019
1Retinal Degeneration
12/2018
1Eye Diseases (Eye Disease)
11/2018
1Degenerative Myopia
01/2018
1Choroid Diseases
12/2012

Drug/Important Bio-Agent (IBA)

24Retinaldehyde (Retinal)IBA
01/2023 - 02/2002
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2022 - 08/2008
7Fluorescein (Funduscein)FDA LinkGeneric
10/2022 - 10/2002
7Bevacizumab (Avastin)FDA Link
09/2015 - 07/2007
6Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
01/2016 - 03/2006
5LipidsIBA
11/2022 - 06/2005
4SuspensionsIBA
04/2015 - 09/2002
4Cidofovir (Vistide)FDA Link
01/2015 - 10/2003
4ProdrugsIBA
01/2012 - 06/2005
3Biomarkers (Surrogate Marker)IBA
01/2024 - 10/2021
3Dexamethasone (Maxidex)FDA LinkGeneric
01/2018 - 12/2014
3Retinal Pigments (Pigments, Visual)IBA
09/2009 - 10/2002
3prinomastat (Ag3340)IBA
10/2004 - 01/2002
2SiliconIBA
11/2022 - 01/2018
2SolutionsIBA
01/2022 - 04/2015
2Triamcinolone (Aristocort)FDA Link
10/2021 - 06/2016
2Lidocaine (Xylocaine)FDA LinkGeneric
06/2021 - 12/2005
2brincidofovirIBA
01/2015 - 12/2011
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2014 - 08/2008
2SteroidsIBA
09/2006 - 06/2004
2Antiviral Agents (Antivirals)IBA
11/2004 - 02/2002
1CytokinesIBA
01/2024
1Small Interfering RNA (siRNA)IBA
11/2022
1IntegrinsIBA
11/2022
1KH902 fusion proteinIBA
12/2021
1Fibrinogen (Factor I)FDA Link
12/2021
1Biocompatible Materials (Biomaterials)IBA
10/2021
1proxymetacaine (Alcaine)FDA LinkGeneric
06/2021
1Hyaluronic Acid (Hyaluronan)IBA
12/2020
1Silicon Dioxide (Silica)FDA LinkGeneric
11/2020
1Polymethyl Methacrylate (Sol)IBA
11/2020
1KetorolacIBA
11/2020
1Ophthalmic Solutions (Eye Drops)IBA
11/2020
1N-acetyltryptophanamide (NATA)IBA
01/2020
1afliberceptIBA
04/2019
1Hypoxia-Inducible Factor 1IBA
11/2018
1matrigelIBA
01/2018
1genipinIBA
01/2018
1caprolactoneIBA
01/2016
1Endothelial Growth FactorsIBA
09/2015
1LipopolysaccharidesIBA
04/2015
1MicellesIBA
01/2015
1Antiglaucoma AgentsIBA
01/2015
1NucleosidesIBA
01/2015
1Daunorubicin (Cerubidine)FDA LinkGeneric
02/2013
1hexadecyloxypropyl cytarabine 5'-monophosphateIBA
01/2012

Therapy/Procedure

17Lasers (Laser)
08/2014 - 09/2002
13Therapeutics
10/2022 - 02/2002
6Intravitreal Injections
12/2020 - 02/2002
6Injections
04/2019 - 02/2002
5Vitrectomy
10/2012 - 08/2002
4Semiconductor Lasers
02/2011 - 10/2002
3Light Coagulation
08/2014 - 10/2002
3Traction
05/2014 - 08/2008
2Aftercare (After-Treatment)
06/2013 - 10/2002
2Highly Active Antiretroviral Therapy (HAART)
03/2006 - 10/2003
1Tissue Transplantation
01/2023
1Prostheses and Implants (Prosthesis)
09/2019
1Visual Prosthesis
12/2018